NDVA.V · Indiva Limited

-

Please sign in to comment on NDVA.V

1 Comment

Admin

4 years ago

Indiva Limited is currently in a long term downtrend where the price is trading 7.4% below its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.6.

Indiva Limited's total revenue rose by 1531.6% to $3M since the same quarter in the previous year.

Its net income has dropped by 36.0% to $-4M since the same quarter in the previous year.

Finally, its free cash flow fell by 56.6% to $-5M since the same quarter in the previous year.

Based on the above factors, Indiva Limited gets an overall score of 2/5.

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	V
CurrencyCode	CAD
ISIN	CA45580J1012

Market Cap	6M
Beta	1.04
PE Ratio	None
Target Price	0.12
Dividend Yield	None

ABOUT

Indiva Limited

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers edibles, capsules and tablets, and vape products under the No Future, Pearls by gron, Bhang Chocolate, Indiva Doppio, Indiva Blips, and Indiva 1432 brands. Indiva Limited is based in Ottawa, Canada.

NDVA.V · Indiva Limited

-

Indiva Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Indiva Limited using a moving average strategy